Please login to the form below

Not currently logged in
Email:
Password:

Paolo Casati named as general manager of Santen Italy

Has over 30 years of experience in the sector

Eye care specialist Santen Pharma has appointed Paolo Casati as general manager of its Italian subsidiary.

Casati brings 30 years of management and global business leadership experience in the ophthalmic sector to the role.

From 2012 to 2014, he served as head of sales force effectiveness at Alcon, an eye care specialist that develops and manufactures medicines and devices for eye care needs.

Prior to that, Casati held a number of senior leadership positions at the firm in sales and marketing departments.

Commenting on his appointment, he said: “Santen group is successful thanks to its commitment to the protection and improvement of eyesight and the quality of life of patients.

“I am very excited to join the team to establish Santen Italy as one of the major companies of reference for the ophthalmic world in Italy.”

Highlights of Casati's career include the creation of the EMEA training organisation at Alcon that covers all business units, technical, sales, management and marketing skills.

Masamichi Sato, head of Santen European group and president of Santen holdings, added: “Our expansion in Italy is an important step in achieving global presence in Europe. Paolo Casati's appointment will bring leadership that fits very well with the company's ambition and values.”

11th December 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics